Written by Laura Dyrda
Smith & Nephew announced a new sales model, called Syncera, geared toward hospitals to lower prices on hip and knee implants, according to a Health Point Capital report.
Syncera includes two Smith & Nephew primary hip and knee implants and hospitals that decide to bite will sign a multiyear contract with discount rates of around one-third the initial price. The implants included in the deal are the Genesis II Knee and the Synergy hip stem and reflection cap.
According to the report, these two products could be used in 80 percent of all hip and knee procedures performed in the country. But these price cuts don’t mean there won’t be any operating room service; the program still includes operating room technical support and supplemental technology to streamline supply chain. Syncera will result in dilution for Smith & Nephew to begin, but the company expects to maintain margins current margins in the long run.
